COMMUNIQUÉS West-GlobeNewswire

Beroni Group Expands Into Strategic Relationship With Jinshui Science & Education Park In Zhengzhou, China
03/09/2019
PLACEHOLDER, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Beroni Group Limited (NSX: BTG)(OTCQX: BNIGF) (“Beroni” or the “Company”) and Zhengzhou Jinshui Science & Education Park (“Jinshui Park”) have signed a strategic [...]
Merit Medical to Present at Three Conferences in September
03/09/2019
SOUTH JORDAN, Utah, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]
Ossur HF : Notification of managers and closely related parties’ transactions with Össur hf. shares
03/09/2019
Össur hf. Announcement no. 21/2019 Notification of managers and closely related parties’ transactions with Össur hf. shares. Please see attached files Attachments Kim De Roy_Notification by Managers_buy (03 09 2019) Kim [...]
Taconic Biosciences Participates in Second Rodent Research Reference Mission to the International Space Station
03/09/2019
Resulting Studies Will Provide Critical Reference Data to Drive Advancements in Human Health RENSSELAER, N.Y., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered [...]
Zosano Pharma to Present at the H.C. Wainwright Annual Global Investment Conference
03/09/2019
FREMONT, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its chairman, president and chief executive officer, John [...]
Rafarma Announces the Cancellation of All Outstanding Preferred A Shares, Removing Obstacles to Further Growth
03/09/2019
Ljubljana, Slovenia, Sept. 03, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” - Rafarma Pharmaceuticals, Inc. announces the cancellation of all outstanding Preferred Class A shares. On August 28th, [...]
Novan to Participate in H.C. Wainwright 21st Annual Global Investment Conference
03/09/2019
MORRISVILLE, N.C., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that it will participate in the H.C. Wainwright 21st Annual Global Investment Conference in New [...]
Obalon Engages Helmuth T. Billy, MD as Medical Director for its First Company-Owned Weight Loss Treatment Center
03/09/2019
Leading bariatric surgeon and authority in the field to oversee medical activities for the Obalon Center for Weight Loss located in San Diego, CA. SAN DIEGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc [...]
Adamis Pharmaceuticals Provides Update for Naloxone Product Candidate
03/09/2019
SAN DIEGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today the completion of pharmacokinetic (PK) studies comparing its naloxone injection product candidate, ZIMHI TM [...]
Abeona Therapeutics annonce un examen stratégique
03/09/2019
La société engage Jefferies LLC en réponse à un intérêt stratégique que celle-ci lui a manifesté NEW YORK et CLEVELAND, 03 sept. 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), leader entièrement [...]
Radius Health to Participate in the Citi 14th Annual Biotech Conference and Morgan Stanley 17th Annual Global Healthcare Conference in September
03/09/2019
WALTHAM, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS) today announced its participation in the following conferences in September 2019. Radius Health management will host meetings with [...]
Abeona Therapeutics Announces Strategic Review
03/09/2019
Company engages Jefferies LLC in response to strategic inbound interest NEW YORK and CLEVELAND, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell [...]
Feng Lin, MD, Ph.D., Joins Therapeutic Solutions International as Chief Scientific Officer
03/09/2019
Immuno-Oncology Nutraceutical Company Positions Itself for Expansion into FDA OCEANSIDE, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc., ( OTC Markets: TSOI ) [...]
Calithera Biosciences to Present New Data on Two Oncology Programs at ESMO Congress 2019
03/09/2019
-Results from ENTRATA Phase 2 trial of telaglenastat in patients with advanced renal cell carcinoma (RCC) accepted as Late Breaking Oral Presentation- -Data from INCB001158 clinical program accepted as Oral Presentation [...]
The European Society of Cardiology Includes Neovasc Reducer™ for the Treatment of Refractory Angina in the European Practice Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes
03/09/2019
Announcement Made at European Society of Cardiology Congress 2019 in Paris, France VANCOUVER, British Columbia, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader [...]
Golden Leaf Holdings Ltd. Appoints Jeffrey Yapp as New CEO
03/09/2019
Seasoned Marketer and Entrepreneur with Global Tech and Consumer Brand Experience Charged with Scaling Business into Key Markets TORONTO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: [...]
Allogene Therapeutics Announces September 2019 Investor Conference Schedule
03/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies [...]
Eyenovia to Present at Two Upcoming Investor Conferences
03/09/2019
NEW YORK, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print [...]
Progenics Pharmaceuticals Announces Presentation at the International Conference on Immunotherapy Radiotherapy Combinations
03/09/2019
NEW YORK, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and follow cancer, today [...]

Pages